20622 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
BIOENGINEERING TERITIARY LYMPHOID STRUCTURES USING CHITOSAN-BASED HYDROGELS
#2COMPOSITION FOR CANCER IMMUNOTHERAPY COMPRISING SECONDARY LYMPHOID ORGAN-DERIVED EXTRACELLULAR VESICLE AS ACTIVE INGREDIENT
#3METHODS FOR IMPROVING COGNITIVE FUNCTION
#4ALTERING GENE EXPRESSION IN CART CELLS AND USES THEREOF
#5GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#6METHOD FOR TREATING OSTEOARTHRITIS WITH MESENCHYMAL STEM CELL EXOSOMES
#7USE OF BOVINE SPLEEN PEPTIDE POWDER IN IMPROVING SLEEP, PREVENTING OR TREATING DEPRESSION, OR IMPROVING INTESTINAL FUNCTION
#8LYMPH NODE AS A SITE FOR TRANSPLANTATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES AND ORGANS
#9Methods of Determining the Suitability of Cultured Thymus Tissue for Implantation Into Humans and Associated Methods of Use
#10LYMPH NODE AS A SITE FOR TRANSPLANTATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES AND ORGANS
#11T CELL MODIFYING COMPOUNDS AND USES THEREOF
#12Cultured Thymus Tissue Transplantation Promotes Donor-Specific Tolerance to Allogeneic Solid Organ Transplants
#13THYMIC EPITHELIAL STEM CELLS
#14THYMIC CELLS AND METHODS OF MAKING
#15METHODS OF INDUCING ORGAN TRANSPLANTATION IMMUNE TOLERANCE AND ASSOCIATED COMPOSITIONS AND METHODS
#16IMMUNOMODULATION FOR THE LONG TERM PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES AND FOREIGN TISSUE REJECTION
#17Altering Gene Expression in CART Cells and Uses Thereof
#18ISOLATION AND USE OF HUMAN LYMPHOID ORGAN-DERIVED SUPPRESSIVE STROMAL CELLS
#19THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1
#20CD38-NAD+ REGULATED METABOLIC AXIS IN ANTI-TUMOR IMMUNOTHERAPY
#21EP4 INHIBITORS AND USE THEREOF
#22COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE
#23Methods for Generating Thymic Cells in Vitro
#24Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
#25THYMUS ORGANOIDS BIOENGINEERED FROM HUMAN PLURIPOTENT STEM CELLS
#26T CELL MODIFYING COMPOUNDS AND USES THEREOF
#27Methods and Compositions for Treating Cancer
#28LYMPH NODE AS A SITE FOR TRANSPLANTATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES AND ORGANS
#29TRANSGENIC SWINE, METHODS OF MAKING AND USES THEREOF, AND METHODS OF MAKING HUMAN IMMUNE SYSTEM MICE
#30PARTHENOGENIC ACTIVATION OF HUMAN OOCYTES FOR THE PRODUCTION OF HUMAN EMBRYONIC STEM CELLS
#31Altering Gene Expression in Modified T Cells and Uses Thereof
#32AUTOLOGOUS THYMIC TISSUE TRANSPLANTATION
#33Altering Gene Expression in Modified T Cells and Uses Thereof
#34METHODS OF PROMOTING THYMIC EPITHELIAL CELL AND THYMIC EPITHELIAL CELL PROGENITOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS, RESULTING CELLS, AND USES THEREOF
#35METHODS FOR IMPROVING COGNITIVE FUNCTION
#36METHOD FOR TREATING OSTEOARTHRITIS WITH A COMBINATION OF MESENCHYMAL STEM CELL EXOSOMES, SYNOVIAL MESENCYMAL STEM CELLS, AND SCAFFOLDS
#37COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS
#38GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
#39Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#40GENERATION OF FUNCTIONAL AND PATIENT-SPECIFIC THYMIC TISSUE IN VIVO FROM INDUCED PLURIPOTENT STEM CELLS
#41Conditioning regimens and methods for inducing mixed chimerism
#42COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#43FETAL TISSUE EXTRACT, METHODS FOR PRODUCING THE EXTRACT, AND THE USE THEREOF
#44COMPOSITIONS WITH ANTIVIRAL ACTIVITY AND RELATED METHODS
#45EP4 INHIBITORS AND USE THEREOF
#46CAR EXPRESSION VECTOR AND CAR-EXPRESSING T CELLS
#47BIOENGINEERING TERTIARY LYMPHOID STRUCTURES USING CHITOSAN-BASED HYDROGELS
#48ADIPONECTIN-EXPRESSING REGULATORY T-CELL PRECURSORS, COMPOSITION AND METHODS THEREOF
#49Altering Gene Expression in CART Cells and Uses Thereof
#50METHODS OF DETERMINING THE SUITABILITY OF CULTURED THYMUS TISSUE FOR IMPLANTATION INTO HUMANS AND ASSOCIATED METHODS OF USE
#51Method for Combination Cold Atmospheric Plasma and CAR-T Therapy
#52Genetically modified cells, tissues, and organs for treating disease
#53PYRIMIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
#54Therapeutic heterocyclic compounds
#55In vitro generation of thymic organoid from human pluripotent stem cells
#56ISOLATION AND USE OF HUMAN LYMPHOID ORGAN-DERIVED SUPPRESSIVE STROMAL CELLS
#57THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1
#58NANOSTRAWS METHODS AND APPARATUSES
#59CAR expression vector and CAR-expressing T cells
#60EP4 inhibitors and use thereof
#61METHOD FOR IN-SITU RADIATION-PRIMED T-CELL THERAPY
#62Compositions and libraries comprising recombinant T-cell receptors and methods of using recombinant T-cell receptors
#63Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#64CD38-NAD+ regulated metabolic axis in anti-tumor immunotherapy
#65Genetically modified cells, tissues, and organs for treating disease
#66Therapeutic heterocyclic compounds
#67Methods and compositions for treating cancer
#68Immune stimulatory function and anti-tumor activity of TGF-β primed myeloid derived suppressor cells (MDSC)
#69Compositions and methods for modulating an immune response
#70Methods and systems for modulating physiological states between biological entities
#71Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection
#72Conditioning regimens and methods for inducing mixed chimerism
#73Altering gene expression in modified T cells and uses thereof
#74Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#75Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
#76Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
#77Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying Treg cells to produce therapeutic vaccine for treatment of diabetes type 1
#78Genetically modified cells, tissues, and organs for treating disease
#79IMP-3 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#80Altering Gene Expression in CART Cells and Uses Thereof
#81Car expression vector and car-expressing T cells
#82Altering gene expression in modified T cells and uses thereof
#83T cell modifying compounds and uses thereof
#84METHODS AND COMPOUNDS FOR PHOTOTHERAPY WITH CHALCOGENORHODAMINE PHOTOSENSITIZERS
#85Compositions and methods for treating itching, gingivostomatitis, and demodectic mange
#86Method and device for lymphedema treatment
#87Acellular pro-inflammatory compositions, process for making same and methods of using same
#88Genetically modified cells, tissues, and organs for treating disease
#89Parthenogenic activation of human oocytes for the production of neuronal cells
#90IMP-3 epitope peptides for TH1 cells and vaccines containing the same
#91Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
#92COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#93Method of preparing apoptotic monocytes
#94Isolation and use of human lymphoid organ-derived suppressive stromal cells
#95Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#96Disease treatment via developing non-syngeneic graft transplantation
#97Glycosphingolipids for use in modulating immune responses
#98Targeted disruption of T cell receptor genes using talens
#99Tumor Selective Chemokine Modulation
#100ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS OF PRODUCING SAME AND USE OF SAME IN TRANSPLANTATION AND DISEASE TREATMENT
#101Methods and compositions for treating autoimmune diseases
#102Antigen-specific central-memory T cell preparations having high CD4+ fraction
#103T cell modifying compounds and uses thereof
#104Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery
#105Methods of treatment using thymus-derived compositions
#106Isolation of lymphocytes and delivery to splenectomy patients
#107Synthetic peptide that induces expression of TNF receptor 2 and use thereof
#108Adoptive cell therapy with young T cells
#109Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration
#110IMMUNOSUPPRESSIVE DRUG COMBINATION FOR A STABLE AND LONG TERM ENGRAFTMENT
#111Regulatory immune cells with enhanced targeted cell death effect
#112Methods for reducing pulmonary uptake of intravenously injected cells
#113VACCINES WITH ONCOFETAL ANTIGEN/ILRP-LOADED AUTOLOGOUS DENDRITIC CELLS AND USES THEREOF
#114Methods and compositions for treating autoimmune diseases
#115Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension
#116METHODS OF TREATMENT USING THYMUS-DERIVED COMPOSITIONS
#117Conditioned medium and proliferated cell lines produced therefrom
#118AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY
#119Compositions and methods for modulating ischemic injury
#120Complete human monoclonal IgG4lambda specific for CTLA-4 and uses thereof for detection of soluble CTLA-4 and isolation of regulatory cells
#121Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection
#122Adoptive cell therapy with young T cells
#123Methods of treatment of arthritis using thymus-derived compositions
#124Methods of treatment using thymus-derived compositions
#125HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN KRTCAP3 AND LIGANDS FOR THE PROTEIN KRTCAP3
#126Lymph nodes as a site for regeneration
#127Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
#128Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
#129METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES
#130NOVEL THYMIC CELLULAR POPULATIONS AND USES THEREOF
#131PROTEINS FOR USE IN DIAGNOSING AND TREATING INFECTION AND DISEASE
#132Methods and compositions for treating autoimmune diseases
#133Method of producing lymphocytes
#134GLP-1 PHARMACEUTICAL COMPOSITIONS
#135Methods of organ regeneration using Hox11-expressing pluripotent cells
#136METHODS FOR TREATING VIRAL DISORDERS
#137Disease treatment via developing non-syngeneic graft transplantation
#138Treatment of inflammatory bowel disease
#139Artificial lymph node for treating cancer
#140Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
#141Method of isolating regulatory T cells from human samples
#142METHOD FOR REGENERATING AN IMMUNE SYSTEM
#143Use of dendrimers to stimulate cell growth
#144Method for treating colon cancer with tumour-reactive T-lymphocytes
#145COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS
#146Method of treating solid tumor
#147PARATHYROID AND THYMUS TRANSPLANTATION IN DIGEORGE SYNDROME SUBJECTS
#148Method of Treating Cognitive Decline and Synaptic Loss Related to Alzheimer's Disease
#149AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY
#150Method for the production of a cell composition containing epithelial cells
#151Proliferated cell lines and uses thereof
#152Pre- and intra-operative imaging of bladder cancer
#153Process for producing engineered targeted T cell and medicine
#154Biostimulate and tonic solution for massage (solution "Biplatvirs")
#155Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells
#156Hox11+, CD45− cells and methods of organ regeneration using the same
#157Immunotherapy based on dendritic cells
#158Fugetactic proteins, compositions and methods of use
#159Allogeneic and xenogeneic transplantation
#160Disease therapy using dying or dead cells
#161Method of treatment and agents useful for same
#162Methods of organ regeneration using -expressing pluripotent cells
#163Method for immune response eliciting in a mammal
#164Induction of tolerance by apoptotic and/or necrotic cells